{"id":"https://genegraph.clinicalgenome.org/r/416a11df-b73f-4434-9e8f-14eecc235a50v1.0","type":"EvidenceStrengthAssertion","dc:description":"*A4GALT* was first reported in relation to autosomal recessive congenital disorder of glycosylation in 2000 (Steffensen et al., PMID: 10747952). *A4GALT*-congenital disorder of glycosylation presents as the blood group phenotype p null. Persons affected with this condition may present with no phenotype beyond abnormal agglutination in standard blood group serological testing or may present with recurrent spontaneous abortion or congenital hemolytic anemia. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found a difference in molecular mechanism. Therefore, the following disease entities have been split into multiple disease entities, congenital disorder of glycosylation and NOR polyagglutination syndrome. The split curation for autosomal recessive NOR polyagglutination syndrome will be curated separately. 14 variants (missense, in-frame indel, nonsense, frameshift) that have been reported in 13 probands in 6 publications (PMIDs: 12823750, 15142124, 10747952, 10993874, 11896312, 27612185) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by in vitro functional assays. (PMIDs: 23927681, 18067504). In summary, there is definitive evidence supporting the relationship between *A4GALT* and autosomal recessive congenital disorder of glycosylation. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date May 21, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/416a11df-b73f-4434-9e8f-14eecc235a50","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-05-30T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-05-30T20:58:57.436Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/239edc2e-4f09-4e59-a2a6-b02f71e88b92","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df3cb11e-cdad-451a-b7ea-7db62d17b23d","type":"FunctionalAlteration","dc:description":"Transfection in the Namalwa cell line showed lack of activity comparable to negative control.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18067504","rdfs:label":"Hellberg Namalwa cell line Transfection"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e97f1382-9a02-472f-a45c-e46f6f8744cb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef191692-4378-46f5-940a-be4d980fcd11","type":"FunctionalAlteration","dc:description":"Transfection of the construct in MEG-01 cells showed no induction of Pk or P1 antigen expression on cell surface.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23927681","rdfs:label":"Westman MEG-01 cell transfection"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7e3a8df0-77f1-4395-b501-63a96016e515_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/065f5dfb-8fad-4b15-b76e-19f81468e349_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1620aa36-fbcc-4a06-bae4-385e2f2a0baf","type":"EvidenceLine","dc:description":"NMD- variant, score reduced.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1620aa36-fbcc-4a06-bae4-385e2f2a0baf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression vectors in L cells showed minimal Gb3 expression (fig 2A). All mutants exhibited loss of enzyme activity (fig 3A).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1620aa36-fbcc-4a06-bae4-385e2f2a0baf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","allele":{"id":"https://genegraph.clinicalgenome.org/r/e926327f-2934-44a9-9f32-2963796ded52","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.783G>A (p.Trp261Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115687"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/065f5dfb-8fad-4b15-b76e-19f81468e349","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","rdfs:label":"Furukawa J4","allele":{"id":"https://genegraph.clinicalgenome.org/r/e926327f-2934-44a9-9f32-2963796ded52"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1620aa36-fbcc-4a06-bae4-385e2f2a0baf_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/ad02ffbe-f222-43fc-ad69-77b1726cf61a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be095da9-59ef-4336-8b82-20426031c348","type":"EvidenceLine","dc:description":"NMD-, score reduced","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be095da9-59ef-4336-8b82-20426031c348_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","allele":{"id":"https://genegraph.clinicalgenome.org/r/b89c1d1b-27de-454f-85cc-b994be04217c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.68dup (p.Phe24ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230999"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ad02ffbe-f222-43fc-ad69-77b1726cf61a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","rdfs:label":"Hellberg Israeli patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/b89c1d1b-27de-454f-85cc-b994be04217c"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phentoype","previousTesting":true,"previousTestingDescription":"p null confirmed via blood group serology","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/be095da9-59ef-4336-8b82-20426031c348_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/aefacd37-6152-4275-83ac-4353e33eea3f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/277c37c2-8b25-4f0a-b269-01246647536f","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/277c37c2-8b25-4f0a-b269-01246647536f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression vectors in L cells showed no Gb3 expression (fig 2A). All mutants exhibited loss of enzyme activity (fig 3A).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/277c37c2-8b25-4f0a-b269-01246647536f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","allele":{"id":"https://genegraph.clinicalgenome.org/r/d14e0c75-f903-44c3-a388-be62bc7ad126","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.752C>T (p.Pro251Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115685"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/aefacd37-6152-4275-83ac-4353e33eea3f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","rdfs:label":"Furukawa J1","allele":{"id":"https://genegraph.clinicalgenome.org/r/d14e0c75-f903-44c3-a388-be62bc7ad126"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/277c37c2-8b25-4f0a-b269-01246647536f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/94ca5dc9-5538-4309-9bfe-b1f6b1a5629d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f423d582-6725-4b90-9593-126c7676acc9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f423d582-6725-4b90-9593-126c7676acc9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","allele":{"id":"https://genegraph.clinicalgenome.org/r/739eca05-c52c-4f6f-90d1-1a7fd7249478","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.656C>T (p.Ala219Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10270247"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/96ac6870-1c48-4465-b08b-d364d4e5b208","type":"EvidenceLine","dc:description":"NMD-, reduced score","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96ac6870-1c48-4465-b08b-d364d4e5b208_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","allele":{"id":"https://genegraph.clinicalgenome.org/r/14644291-4d37-416e-9bc0-5a71d7cb399b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.972_997del (p.Arg325AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10270164"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/94ca5dc9-5538-4309-9bfe-b1f6b1a5629d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","rdfs:label":"Hellberg French patient","allele":[{"id":"https://genegraph.clinicalgenome.org/r/739eca05-c52c-4f6f-90d1-1a7fd7249478"},{"id":"https://genegraph.clinicalgenome.org/r/14644291-4d37-416e-9bc0-5a71d7cb399b"}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","previousTesting":true,"previousTestingDescription":"p null confirmed with blood group serology","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f423d582-6725-4b90-9593-126c7676acc9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/96ac6870-1c48-4465-b08b-d364d4e5b208_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/fac6e687-676d-49a6-9515-beb8bc3df801_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9f0e029-4292-4458-8da8-449f4d9d7836","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9f0e029-4292-4458-8da8-449f4d9d7836_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression vectors in L cells showed no Gb3 expression (fig 2A). All mutants exhibited loss of enzyme activity (fig 3A).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e9f0e029-4292-4458-8da8-449f4d9d7836_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","allele":{"id":"https://genegraph.clinicalgenome.org/r/b16332b6-84b5-46fe-bd5b-c3732732cadb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.548T>A (p.Met183Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115683"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/fac6e687-676d-49a6-9515-beb8bc3df801","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","rdfs:label":"Furukawa S2","allele":{"id":"https://genegraph.clinicalgenome.org/r/b16332b6-84b5-46fe-bd5b-c3732732cadb"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9f0e029-4292-4458-8da8-449f4d9d7836_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bfa4ba27-ecab-4bad-b620-932543b37f42_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/458fc689-a470-4305-9e6f-35594c56e8d3","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/458fc689-a470-4305-9e6f-35594c56e8d3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression of coding construct in insect (High Five) cells showed no galactosyltransferase activity with this variant (fig 4).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/458fc689-a470-4305-9e6f-35594c56e8d3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10747952","allele":{"id":"https://genegraph.clinicalgenome.org/r/b16332b6-84b5-46fe-bd5b-c3732732cadb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bfa4ba27-ecab-4bad-b620-932543b37f42","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10747952","rdfs:label":"Steffensen Individual 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b16332b6-84b5-46fe-bd5b-c3732732cadb"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p (p null) phenotype","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/458fc689-a470-4305-9e6f-35594c56e8d3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/eeda3b7f-729d-43ab-912a-6266cc86f71d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcdc03a4-de93-432f-a569-4c3a5ee7b304","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcdc03a4-de93-432f-a569-4c3a5ee7b304_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","allele":{"id":"https://genegraph.clinicalgenome.org/r/9743c1c0-0cdd-4fb0-bcc9-4e72e6372213","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.241_243del (p.Phe81del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115691"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/eeda3b7f-729d-43ab-912a-6266cc86f71d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","rdfs:label":"Hellberg Italian patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/9743c1c0-0cdd-4fb0-bcc9-4e72e6372213"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","previousTesting":true,"previousTestingDescription":"p null confirmed via blood group serology","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/dcdc03a4-de93-432f-a569-4c3a5ee7b304_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/98603d48-89a2-4449-bb4b-b5b2c1bd1ebb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7a86f13-5623-4cdb-84a8-06aa27a85dc5","type":"EvidenceLine","dc:description":"NMD-, reduced score","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7a86f13-5623-4cdb-84a8-06aa27a85dc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4bb4f26-92e4-4fd0-99af-83d8308ba783","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.473G>A (p.Trp158Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411812276"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/98603d48-89a2-4449-bb4b-b5b2c1bd1ebb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15142124","rdfs:label":"Hellberg Brazilian patient","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4bb4f26-92e4-4fd0-99af-83d8308ba783"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","previousTesting":true,"previousTestingDescription":"p null confirmed with blood group serology","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7a86f13-5623-4cdb-84a8-06aa27a85dc5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cc7e1eee-702e-44a3-86cb-175729cadad0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fce983a0-940d-430f-ba46-310cd6f61510","type":"EvidenceLine","dc:description":"NMD-, reduced score","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fce983a0-940d-430f-ba46-310cd6f61510_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27612185","allele":{"id":"https://genegraph.clinicalgenome.org/r/6493ff86-8e71-4709-b31b-a32f8c7e7089","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.345del (p.Leu117PhefsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230998"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cc7e1eee-702e-44a3-86cb-175729cadad0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27612185","rdfs:label":"Li proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/6493ff86-8e71-4709-b31b-a32f8c7e7089"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","phenotypes":"obo:HP_0200067","previousTesting":true,"previousTestingDescription":"anti-PP1PK antibody identified in blood group serology","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fce983a0-940d-430f-ba46-310cd6f61510_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0b6c56e7-94db-4989-823b-321f6885624f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e76a072-eac0-4a05-98d4-c1db43b1ad7a","type":"EvidenceLine","dc:description":"NMD-, reducing variant score.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e76a072-eac0-4a05-98d4-c1db43b1ad7a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11896312","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c56a2d3-5236-4137-a618-2a3fa756ebd2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.1029dup (p.Thr344HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115693"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0b6c56e7-94db-4989-823b-321f6885624f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11896312","rdfs:label":"Koda p(1029-1030insC) individual","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c56a2d3-5236-4137-a618-2a3fa756ebd2"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7e76a072-eac0-4a05-98d4-c1db43b1ad7a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/426946e9-7a99-4bc6-a1ab-e5d62673fd7d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cdbeb8d-77af-463c-9dba-4fbea3075720","type":"EvidenceLine","dc:description":"NMD-, reduced score","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cdbeb8d-77af-463c-9dba-4fbea3075720_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12823750","allele":{"id":"https://genegraph.clinicalgenome.org/r/53d3c854-ab36-4363-a11e-94d514519000","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.657del (p.Phe220SerfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2406870223"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/426946e9-7a99-4bc6-a1ab-e5d62673fd7d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12823750","rdfs:label":"Hellberg Israeli Jewish proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/53d3c854-ab36-4363-a11e-94d514519000"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","phenotypes":"obo:HP_0200067","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1cdbeb8d-77af-463c-9dba-4fbea3075720_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/51e45a65-d85c-4b38-b383-662eb9dc0faf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6620b756-bc09-419c-924d-41d58f0029bb","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6620b756-bc09-419c-924d-41d58f0029bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11896312","allele":{"id":"https://genegraph.clinicalgenome.org/r/9743c1c0-0cdd-4fb0-bcc9-4e72e6372213"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/51e45a65-d85c-4b38-b383-662eb9dc0faf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11896312","rdfs:label":"Koda p(237- 239delCTT) individual","allele":{"id":"https://genegraph.clinicalgenome.org/r/9743c1c0-0cdd-4fb0-bcc9-4e72e6372213"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6620b756-bc09-419c-924d-41d58f0029bb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/41e4988b-e561-4d63-b619-1880c725944d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c243f9a6-8ca9-44c7-8b30-82bdcf55a84a","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c243f9a6-8ca9-44c7-8b30-82bdcf55a84a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression vectors in L cells showed minimal Gb3 expression (fig 2A). All mutants exhibited loss of enzyme activity (fig 3A).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c243f9a6-8ca9-44c7-8b30-82bdcf55a84a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f2784b8-ebf2-4f0d-8ebe-a90728075602","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017436.7(A4GALT):c.560G>A (p.Gly187Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115689"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/41e4988b-e561-4d63-b619-1880c725944d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10993874","rdfs:label":"Furukawa S1","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f2784b8-ebf2-4f0d-8ebe-a90728075602"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"p null phenotype","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c243f9a6-8ca9-44c7-8b30-82bdcf55a84a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10509,"specifiedBy":"GeneValidityCriteria11","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/QDJjiwzs6v4","type":"GeneValidityProposition","disease":"obo:MONDO_0100587","gene":"hgnc:18149","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7e3a8df0-77f1-4395-b501-63a96016e515-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}